Finoriq research workspace
Aardvark Therapeutics, Inc. (AARD) Institutional Holdings & 13F Ownership
Track institutional investor activity, 13F holders, portfolio weights, and reported position changes for Aardvark Therapeutics, Inc. (AARD).
Company Snapshot
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
- Company
- Aardvark Therapeutics, Inc. (AARD)
- Ticker
- AARD
- Market Cap
- $120.9M
- Latest Price
- $5.525
- Industry
- Biotech & Pharma
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.